Cargando…

Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison

BACKGROUND: The methylotrophic yeast Pichia pastoris is a common host for the production of recombinant proteins. However, hypermannosylation hinders the use of recombinant proteins from yeast in most biopharmaceutical applications. Glyco-engineered yeast strains produce more homogeneously glycosyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Pekarsky, Alexander, Veiter, Lukas, Rajamanickam, Vignesh, Herwig, Christoph, Grünwald-Gruber, Clemens, Altmann, Friedrich, Spadiut, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260843/
https://www.ncbi.nlm.nih.gov/pubmed/30474550
http://dx.doi.org/10.1186/s12934-018-1032-6
_version_ 1783374873138036736
author Pekarsky, Alexander
Veiter, Lukas
Rajamanickam, Vignesh
Herwig, Christoph
Grünwald-Gruber, Clemens
Altmann, Friedrich
Spadiut, Oliver
author_facet Pekarsky, Alexander
Veiter, Lukas
Rajamanickam, Vignesh
Herwig, Christoph
Grünwald-Gruber, Clemens
Altmann, Friedrich
Spadiut, Oliver
author_sort Pekarsky, Alexander
collection PubMed
description BACKGROUND: The methylotrophic yeast Pichia pastoris is a common host for the production of recombinant proteins. However, hypermannosylation hinders the use of recombinant proteins from yeast in most biopharmaceutical applications. Glyco-engineered yeast strains produce more homogeneously glycosylated proteins, but can be physiologically impaired and show tendencies for cellular agglomeration, hence are hard to cultivate. Further, comprehensive data regarding growth, physiology and recombinant protein production in the controlled environment of a bioreactor are scarce. RESULTS: A Man(5)GlcNAc(2) glycosylating and a Man(8–10)GlcNAc(2) glycosylating strain showed similar morphological traits during methanol induced shake-flask cultivations to produce the recombinant model protein HRP C1A. Both glyco-engineered strains displayed larger single and budding cells than a wild type strain as well as strong cellular agglomeration. The cores of these agglomerates appeared to be less viable. Despite agglomeration, the Man(5)GlcNAc(2) glycosylating strain showed superior growth, physiology and HRP C1A productivity compared to the Man(8–10)GlcNAc(2) glycosylating strain in shake-flasks and in the bioreactor. Conducting dynamic methanol pulsing revealed that HRP C1A productivity of the Man(5)GlcNAc(2) glycosylating strain is best at a temperature of 30 °C. CONCLUSION: This study provides the first comprehensive evaluation of growth, physiology and recombinant protein production of a Man(5)GlcNAc(2) glycosylating strain in the controlled environment of a bioreactor. Furthermore, it is evident that cellular agglomeration is likely triggered by a reduced glycan length of cell surface glycans, but does not necessarily lead to lower metabolic activity and recombinant protein production. Man(5)GlcNAc(2) glycosylated HRP C1A production is feasible, yields active protein similar to the wild type strain, but thermal stability of HRP C1A is negatively affected by reduced glycosylation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1032-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6260843
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62608432018-12-10 Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison Pekarsky, Alexander Veiter, Lukas Rajamanickam, Vignesh Herwig, Christoph Grünwald-Gruber, Clemens Altmann, Friedrich Spadiut, Oliver Microb Cell Fact Research BACKGROUND: The methylotrophic yeast Pichia pastoris is a common host for the production of recombinant proteins. However, hypermannosylation hinders the use of recombinant proteins from yeast in most biopharmaceutical applications. Glyco-engineered yeast strains produce more homogeneously glycosylated proteins, but can be physiologically impaired and show tendencies for cellular agglomeration, hence are hard to cultivate. Further, comprehensive data regarding growth, physiology and recombinant protein production in the controlled environment of a bioreactor are scarce. RESULTS: A Man(5)GlcNAc(2) glycosylating and a Man(8–10)GlcNAc(2) glycosylating strain showed similar morphological traits during methanol induced shake-flask cultivations to produce the recombinant model protein HRP C1A. Both glyco-engineered strains displayed larger single and budding cells than a wild type strain as well as strong cellular agglomeration. The cores of these agglomerates appeared to be less viable. Despite agglomeration, the Man(5)GlcNAc(2) glycosylating strain showed superior growth, physiology and HRP C1A productivity compared to the Man(8–10)GlcNAc(2) glycosylating strain in shake-flasks and in the bioreactor. Conducting dynamic methanol pulsing revealed that HRP C1A productivity of the Man(5)GlcNAc(2) glycosylating strain is best at a temperature of 30 °C. CONCLUSION: This study provides the first comprehensive evaluation of growth, physiology and recombinant protein production of a Man(5)GlcNAc(2) glycosylating strain in the controlled environment of a bioreactor. Furthermore, it is evident that cellular agglomeration is likely triggered by a reduced glycan length of cell surface glycans, but does not necessarily lead to lower metabolic activity and recombinant protein production. Man(5)GlcNAc(2) glycosylated HRP C1A production is feasible, yields active protein similar to the wild type strain, but thermal stability of HRP C1A is negatively affected by reduced glycosylation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12934-018-1032-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-24 /pmc/articles/PMC6260843/ /pubmed/30474550 http://dx.doi.org/10.1186/s12934-018-1032-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pekarsky, Alexander
Veiter, Lukas
Rajamanickam, Vignesh
Herwig, Christoph
Grünwald-Gruber, Clemens
Altmann, Friedrich
Spadiut, Oliver
Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title_full Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title_fullStr Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title_full_unstemmed Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title_short Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison
title_sort production of a recombinant peroxidase in different glyco-engineered pichia pastoris strains: a morphological and physiological comparison
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260843/
https://www.ncbi.nlm.nih.gov/pubmed/30474550
http://dx.doi.org/10.1186/s12934-018-1032-6
work_keys_str_mv AT pekarskyalexander productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT veiterlukas productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT rajamanickamvignesh productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT herwigchristoph productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT grunwaldgruberclemens productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT altmannfriedrich productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison
AT spadiutoliver productionofarecombinantperoxidaseindifferentglycoengineeredpichiapastorisstrainsamorphologicalandphysiologicalcomparison